BusinessAdmin•Yahoo Finance RSS•5 hours ago
Legend Biotech Sees Surge After Positive Ratings and Price Target Increase
Legend Biotech's stock surged 18% after receiving positive analyst ratings and an increased price target.
- • Legend Biotech's stock rose by 18% following a series of bullish ratings from analysts.
- • The company received an upgraded price target, reflecting increased confidence in its growth potential.
- • Investors are reacting positively to the news, indicating strong market interest in Legend Biotech's future prospects.
Source: Yahoo Finance RSS
Read original →
